Prescribing of paracetamol in patients with chronic renal failure A Drug Utilisation Study (Paracetamol doses in renal failure)

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation
• Data collection methods:
  Secondary use of data

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  Observational study

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  PARACETAMOL
• Medical condition to be studied:
  Renal failure

Population studied

• Short description of the study population:
  Patients aged 45 years or older diagnosed with chronic renal failure received treatment with paracetamol identified from the IMRD database of UK, France and Germany.
• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Special population of interest:
  Renal impaired
• Estimated number of subjects:
  1200000

Study design details

• Main study objective:
  To compare doses of paracetamol in patients with and patients without renal failure.
• Data analysis plan:
  Descriptive analysis.

Documents

Study results

Paracetamol doses_renal failure_results_final